CN1062164C - Oral medicine pill for curing myopia and amblyopia - Google Patents
Oral medicine pill for curing myopia and amblyopia Download PDFInfo
- Publication number
- CN1062164C CN1062164C CN97106811A CN97106811A CN1062164C CN 1062164 C CN1062164 C CN 1062164C CN 97106811 A CN97106811 A CN 97106811A CN 97106811 A CN97106811 A CN 97106811A CN 1062164 C CN1062164 C CN 1062164C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- grams
- pill
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses an oral taking pill used for treating eye diseases, such as myopia, amblyopia, etc., which is mainly prepared from ten traditional Chinese medicines, such as ginseng, radix ophiopogonis, tuckahoe, etc. The pathogenic factors and the pathological mechanisms for forming eye diseases are found out by the research and the analysis of theoretical science and clinical science on the basis of the 'Baojingwan' of a proved recipe handed from the applicant's forefathers and thousands of clinical practice. The relationship of the eye axial length, the lens and the eye cornea is regulated by regulating human viscera in vivo, nourishing the heart, benefiting the intelligence, promoting the production of the body fluid and nourishing blood in order to reduce the diopter to cause the vision to be improved on the basis of human integration. Clinical observations indicate that the total effective rate reaches 96.3%.
Description
The present invention relates to a kind of herbal mixture for the treatment of disease of eye, exactly is a kind of oral medicine pill that is mainly used in treatment myopia, amblyopia.
Myopia, amblyopia are the ophthalmics of easy trouble of current teenager, according to Chinese student's physical health investigate group investigation, seven Han nationality's large, medium and small student's mean vision fraction defectives of-22 years old reach 34.26%, and the age is big more, poor eyesight rate is high more, and is ascendant trend year by year; Theory of Chinese medical science is thought: the acting of refreshing light person fire, " vision " is the embodiment of " fire ", say as " examining distant letter closely ": " husband is refreshing light at order greatly; ... refreshing light person calls natural energy is looked in the order elite also ",, many of successive dynasties ophthalmology scholars: the saying of " hypermetropia is not clear to be not have fire ", " ophthalmology hundred is asked " speech: " order can be near and can not the hyperope unsuccessful because of considering; thus true blood dissipates, and mind extreme deficiency syndrome is so can not reach far also earlier."; In sum, many, the excess of YIN due to YANG-insufficiency dispirited of myopia by the deficiency of vital energy, essence and blood loses empty, and refine and send out more near and suffer from it, so great attention to whole is answered in treatment, regulating functions of ZANG FU-organs, Yin Yang balancing makes essence and blood full, and the order key must be supported.Have in recent years-near about treating, amblyopia a bit report, such as infrared light flicker therapeutic instrument (glasses), Micropole glasses, magnetic therapy etc., said method is the topical therapeutic of controlling ophthalmic with regard to ophthalmic, can only control table and can not effect a permanent cure, it just during treating vision increase, belong to functional raising, after treatment finishes a period of time, vision drops to original level again, and rate height, vision instability can't fundamentally solve myopia, amblyopia problem repeatedly.
The object of the present invention is to provide a kind of oral medicine pill that can fundamentally cure ophthalmics such as myopia, amblyopia, it is at the cause of disease, from the integral body of human body by improving an eye blood flow, coordinate to concern between axis oculi, crystal and the cornea three, reach the purpose that reduces diopter, improves vision, simultaneously comparatively easy in executing the process of controlling, easily accepted by the patient.
Chinese traditional treatment myopia, amblyopia emphasize that dialectical opinion controls, treatment by Chinese herbs with nourish heart, invigorating the liver and kidney, the meridian dredging be main rule, illustrates that people's eyes have confidential relation with human body viscera internal organs meridians, the formation of ophthalmic is relevant with zang-fu disharmony.
The applicant is on the basis of handed down from the older generations of the family proved recipe " eyeball protection bolus ", in conjunction with thousands of routine clinical practices, by research to abstract science and Clinical Science, analyze, found out the cause of disease of ametropic oculopathy, the pathology forming process is because environmental factors or long-term close eye, cause exhausting and look hematozemia, order is lost blood foster, then cause the circumocular extraocular muscles spasm ischemia of parcel, thereby oppression eyeball shell, made originally and be forced to extend with regard to relatively more fragile sclera in growth course, eyeball is under the situation of being forced to extend, and some tissues of ophthalmic are as crystalline lens, the also corresponding reduction of the elasticity of ciliary muscle and regulating power, at this moment eyes just are in the pseudomyopia state, the ischemia spasticity of long-time this muscle is not removed, and it is not smooth to cause aqueous humor to be discharged, and camera oculi anterior is deepened, eyeball back/forth diameter is elongated gradually, at this moment formed true myopia, the elongated back of axis oculi secondary eyeball deutomerite is initial expansion gradually from the ambitus, choroidal vascular lamina attenuation, atrophy, blood vessel is elongated and attenuates, thereby the optical fundus ischemia is more serious; After the optical fundus was in ischemic state, various nutrient substance also can not be supplied eyeball development with blood circulation, in this case, had more accelerated the decrease speed of diopter and vision.
The present invention mainly forms (being that measurement unit is calculated with the quality) by following ten flavor Chinese prescriptions:
Radix Ginseng 3-9 part, Radix Ophiopogonis 10-18 part, Radix Asparagi 10-18 part, Radix Angelicae Sinensis 9-15 part, Poria 15-30 part, Radix Polygalae 3-5 part, Cortex Cinnamomi 3-5 part, Fructus Schisandrae Chinensis 3-6 part, Radix Paeoniae Alba 3-9 part, Rhizoma Acori Graminei 6-12 part.
After above-mentioned ten flavor prescription Chinese medicines were selected, Radix Ginseng, Cortex Cinnamomi were ground 100 mesh sieves separately into powder, and all the other Chinese medicines decoct, are condensed into paste after pre-treatment, add Radix Ginseng and Cortex Cinnamomi after sieving, and mix homogeneously adds adjuvant and makes pill, and it is clothing that the pill outside is selected Cinnabaris for use.
The invention belongs to pill for oral administration, ginseng qi-tonifying makes eye bright, happy Fructus Alpiniae Oxyphyllae, the sweet replenishing vital QI with drugs of warm nature liver of Radix Angelicae Sinensis and give birth to painstaking effort, and each is returned to some extent to make QI and blood, is monarch drug altogether; The spleen invigorating of Poria diuretic, the Radix Polygalae restoring normal coordination between the heart and kidney, Cortex Cinnamomi hot sweet go into kidney, spleen, the heart, Liver Channel, it is supporing yang to mend fire, promoting the flow of QI-blood by warming the meridian, the strong gate of vitality's sun is planted the gas of heart kidney, and a surname leads hundred medicines not to be had institute and avoids out of fear, makes sun long then cloudy from disappearing, and is ministerial drug altogether; The sweet QI invigorating promoting blood circulation of Radix Paeoniae Alba acid, the Rhizoma Acori Graminei blood stasis dispelling of having one's ideas straightened out, allay excitement and make eye bright, the temperature acrid in the mouth is gone into heart channel of Hand-Shaoyin, the liver meridian medicine, the reinforcing the mother-organ for treating deficiency of the son-organ that the deficiency of heart-QI person uses, liver is bitter suddenly mends it with suffering, trimethyl gallic acid is salty goes into liver and the kidney invigorating, and the arduous popular feeling and tonifying the lung are sweetly gone into Middle Palace strengthening the spleen stomach, the gas of convergence dissipation, control platycoria, regulate the balance of the excited and process of inhibition of cerebral cortex, can improve the vision of normal person and persons suffering from ocular disorders and broaden one's vision, Radix Ophiopogonis, Radix Asparagi is nourshing Yin and drynsessmoistening prescription, foster lung promotes the production of body fluid, two medicines share that the male strong gas of Zhu Shengyang medicine is become is soft, hemopoietic and non-blood trouble is adjuvant drug altogether; But medicine let the fire back to its origin such as Cortex Cinnamomi or be this medicine of heart channel wherein must reuse guiding action medicine.It is proper to make a general survey of full side combination, enriches blood and the blood that do not stagnate, and negative and positive are laid equal stress on, and we are for nourishing heart and strengthening the spleen, lung go forward side by side three parts that is QI invigorating and the agent of nourishing blood and melting mutually.
The present invention is from people's integral body, by adjusting to the human body viscera internal organs, the reinforcing the heart Fructus Alpiniae Oxyphyllae, promote the production of body fluid and nourish blood, thereby vision is improved, reduce diopter, show through clinical observation, total effective rate reaches 96.3%, sees that by drug withdrawal 6-9 was visited the result after individual month vision progress person accounts for 21.6%, and the vision person of remaining unchanged accounts for 51.3%; This pill prescription is the Chinese medicine of putting down in writing to some extent in " Pharmacopoea Chinensis ", and raw material is easy to get, and processing is simple, taking convenience, and auxiliary simultaneously acupoint massage effect is better.
Embodiment one:
Radix Ginseng 60 grams, Radix Ophiopogonis 150 grams, Radix Asparagi 150 grams, Radix Angelicae Sinensis 120 grams, Poria 180 grams, Radix Polygalae 45 grams, Cortex Cinnamomi 45 grams, Fructus Schisandrae Chinensis 60 grams, the Radix Paeoniae Alba 60 grams, Rhizoma Acori Graminei 90 grams; Radix Ginseng, Cortex Cinnamomi were ground 100 mesh sieves separately into powder, and all the other Chinese medicines decoct, are condensed into paste after pre-treatment, added Radix Ginseng and Cortex Cinnamomi after sieving, and mix homogeneously adds Mel and makes pill, and it is clothing that the pill outside is selected Cinnabaris for use.
Embodiment two:
Radix Ginseng 30 grams, Radix Ophiopogonis 100 grams, Radix Asparagi 100 grams, Radix Angelicae Sinensis 90 grams, Poria 150 grams, Radix Polygalae 30 grams are kept 30 grams in mind, Fructus Schisandrae Chinensis 30 grams, the Radix Paeoniae Alba 30 grams, Rhizoma Acori Graminei 60 grams, the Radix Astragali 100 grams, Radix Rehmanniae Preparata 100 grams, Concha Haliotidis 90 grams, Magnetitum 90 grams, Semen Cuscutae 100 grams, Semen Plantaginis 60 grams, Flos Chrysanthemi 100 grams, Fructus Ligustri Lucidi 100 grams, Massa Medicata Fermentata 150 grams, Fructus Leonuri 60 grams, Radix Glycyrrhizae Preparata 30 grams; Processing method is with embodiment one.
Embodiment three:
Radix Ginseng 45 grams, Radix Ophiopogonis 125 grams, Radix Asparagi 125 grams, Radix Angelicae Sinensis 105 grams, Poria 165 grams, Radix Polygalae 40 grams, Cortex Cinnamomi 40 grams, Fructus Schisandrae Chinensis 40 grams, the Radix Paeoniae Alba 45 grams, Rhizoma Acori Graminei 75 grams, the Radix Astragali 125 grams, Radix Rehmanniae Preparata 125 grams, Concha Haliotidis 105 grams, Magnetitum 105 grams, Semen Cuscutae 125 grams, Semen Plantaginis 75 grams, Flos Chrysanthemi 125 grams, Fructus Ligustri Lucidi 125 grams, Massa Medicata Fermentata 225 grams, Fructus Leonuri 75 grams, Radix Glycyrrhizae Preparata 40 grams; Processing method is with embodiment one.
Embodiment four:
Radix Ginseng 60 grams, Radix Ophiopogonis 150 grams, Radix Asparagi 150 grams, Radix Angelicae Sinensis 120 grams, Poria 180 grams, Radix Polygalae 45 grams, Cortex Cinnamomi 45 grams, Fructus Schisandrae Chinensis 45 grams, the Radix Paeoniae Alba 60 grams, Rhizoma Acori Graminei 90 grams, the Radix Astragali 150 grams, Radix Rehmanniae Preparata 150 grams, Concha Haliotidis 120 grams, Magnetitum 120 grams, Semen Cuscutae 150 grams, Semen Plantaginis 90 grams, Flos Chrysanthemi 120 grams, Fructus Ligustri Lucidi 180 grams, Massa Medicata Fermentata 300 grams, Fructus Leonuri 90 grams, Radix Glycyrrhizae Preparata 60 grams; Processing method is with embodiment one.
Embodiment five:
Radix Ginseng 75 grams, Radix Ophiopogonis 165 grams, Radix Asparagi 165 grams, Radix Angelicae Sinensis 135 grams, Poria 220 grams, Radix Polygalae 45 grams, Cortex Cinnamomi 45 grams, Fructus Schisandrae Chinensis 50 grams, the Radix Paeoniae Alba 75 grams, Rhizoma Acori Graminei 105 grams, the Radix Astragali 165 grams, Radix Rehmanniae Preparata 165 grams, Concha Haliotidis 135 grams, Magnetitum 120 grams, Semen Cuscutae 165 grams, Semen Plantaginis 105 grams, Flos Chrysanthemi 135 grams, Fructus Ligustri Lucidi 150 grams, Massa Medicata Fermentata 260 grams, Fructus Leonuri 105 grams, Radix Glycyrrhizae Preparata 75 grams; Processing method is with embodiment one.
Embodiment six:
Radix Ginseng 90 grams, Radix Ophiopogonis 180 grams, Radix Asparagi 180 grams, Radix Angelicae Sinensis 150 grams, Poria 310 grams, Radix Polygalae 50 grams, Cortex Cinnamomi 50 grams, Fructus Schisandrae Chinensis 60 grams, the Radix Paeoniae Alba 90 grams, Rhizoma Acori Graminei 120 grams, the Radix Astragali 180 grams, Radix Rehmanniae Preparata 180 grams, Concha Haliotidis 150 grams, Magnetitum 120 grams, Semen Cuscutae 180 grams, Semen Plantaginis 120 grams, Flos Chrysanthemi 150 grams, Fructus Ligustri Lucidi 180 grams, Massa Medicata Fermentata 300 grams, Fructus Leonuri 120 grams, Radix Glycyrrhizae Preparata 90 grams; Processing method is with embodiment one.
For the Radix Astragali in the above-mentioned prescription, Radix Rehmanniae Preparata, Concha Haliotidis, Magnetitum, Semen Cuscutae, Semen Plantaginis, Flos Chrysanthemi, Fructus Ligustri Lucidi, Massa Medicata Fermentata, Fructus Leonuri and Radix Glycyrrhizae Preparata ten Chinese medicine simply only can vary with each individual and to add wherein several flavors and all do not add, such as the liver blood prolonged deficiency, easily give birth to wind heat patient Ke Jia Flos Chrysanthemi, Concha Haliotidis, caused by liver and kidney deficiency, essence and blood can not on hold in order, vision improves slow person and adds Radix Rehmanniae Preparata, the Radix Astragali, Fructus Ligustri Lucidi and Semen Cuscutae, blockage of main and collateral channels, the superciliary ridge person of aching adds Fructus Leonuri, Semen Plantaginis, spleen is warm weak, look the unable person of eyes of a specified duration and add the Radix Astragali, Massa Medicata Fermentata, Radix Glycyrrhizae Preparata etc.This pill all has certain curative effect to visual impairment type ophthalmics such as myopia, amblyopia, optic atrophy, early-stage glaucoma, early stage retina, macular pigment degeneration, as cooperating crest therapy for treating better effects if.
Claims (5)
1. oral medicine pill for the treatment of myopia, amblyopia is characterized in that said composition mainly made by the following raw material medicaments thing: Radix Ginseng 3-9 part, Radix Ophiopogonis 10-18 part, Radix Asparagi 10-18, Radix Angelicae Sinensis 9-15 part, Poria 15-30, Radix Polygalae 3-5 part, Cortex Cinnamomi 3-5 part, Fructus Schisandrae Chinensis 3-6 part, Radix Paeoniae Alba 3-9 part, Rhizoma Acori Graminei 6-12 part.
2. the treatment myopia of claim 1, the oral medicine pill of amblyopia, it is characterized in that it is made by following method: after described prescription Chinese medicine is selected, Radix Ginseng, Cortex Cinnamomi were ground 100 mesh sieves separately into powder, all the other Chinese medicines are after pre-treatment, decoct, be condensed into paste, add Radix Ginseng and Cortex Cinnamomi after sieving, mix homogeneously adds adjuvant and makes pill, and it is clothing that the pill outside is selected Cinnabaris for use.
3. oral medicine pill according to claim 1 and 2 is characterized in that: contained ten flavor Chinese medicines are in following ratio prescription in the pill: 6 parts of Radix Ginsengs, 15 parts of Radix Ophiopogonis, 15 parts of Radix Asparagi, 12 parts of Radix Angelicae Sinensis, 18 parts in Poria, 4.5 parts of Radix Polygalaes, 4.5 parts of Cortex Cinnamomi, 6 parts of Fructus Schisandrae Chinensis, 6 parts of the Radix Paeoniae Albas, 9 parts of Rhizoma Acori Graminei.
4. oral medicine pill according to claim 1 and 2 is characterized in that: also can add following ten Chinese medicines simply in the described pill, concrete prescription proportioning is: Radix Astragali 10-18 part, Radix Rehmanniae Preparata 10-18 part, Concha Haliotidis 9-15 part, Magnetitum 9-12 part, Semen Cuscutae 10-18 part, Semen Plantaginis 6-12 part, Flos Chrysanthemi 10-15 part, Fructus Ligustri Lucidi 10-18 part, Massa Medicata Fermentata 15-30 part, Fructus Leonuri 6-12 part, Radix Glycyrrhizae Preparata 3-9 part.
5. oral medicine pill according to claim 4, it is characterized in that: described ten simply Chinese medicine by following proportioning prescription: 15 parts of the Radixs Astragali, 15 parts of Radix Rehmanniae Preparata, 12 parts of Concha Haliotidis, 12 parts of Magnetitums, 15 parts of Semen Cuscutae, 9 parts of Semen Plantaginiss, 12 parts of Flos Chrysanthemis, 18 parts of Fructus Ligustri Lucidi, 30 parts of Massa Medicata Fermentata, 9 parts of Fructus Leonuris, 6 parts of Radix Glycyrrhizae Preparatas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97106811A CN1062164C (en) | 1997-01-11 | 1997-01-11 | Oral medicine pill for curing myopia and amblyopia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97106811A CN1062164C (en) | 1997-01-11 | 1997-01-11 | Oral medicine pill for curing myopia and amblyopia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1166353A CN1166353A (en) | 1997-12-03 |
CN1062164C true CN1062164C (en) | 2001-02-21 |
Family
ID=5169020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97106811A Expired - Fee Related CN1062164C (en) | 1997-01-11 | 1997-01-11 | Oral medicine pill for curing myopia and amblyopia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1062164C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103099976A (en) * | 2013-01-11 | 2013-05-15 | 管丽丽 | Medicament patch for treating monocular asthenopia |
CN114917299B (en) * | 2022-05-12 | 2023-05-23 | 陕西省中医医院 | Traditional Chinese medicine eye compress preparation for treating teenager adjustable myopia and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1039726A (en) * | 1989-09-04 | 1990-02-21 | 罗勇 | Chinese medicine make eye bright crystal formulations and production method thereof |
CN1086434A (en) * | 1993-01-13 | 1994-05-11 | 王凯 | Medicine for myopia |
CN1122233A (en) * | 1994-11-01 | 1996-05-15 | 张平 | Oral medicine and fumigant liquid for myopia |
-
1997
- 1997-01-11 CN CN97106811A patent/CN1062164C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1039726A (en) * | 1989-09-04 | 1990-02-21 | 罗勇 | Chinese medicine make eye bright crystal formulations and production method thereof |
CN1086434A (en) * | 1993-01-13 | 1994-05-11 | 王凯 | Medicine for myopia |
CN1122233A (en) * | 1994-11-01 | 1996-05-15 | 张平 | Oral medicine and fumigant liquid for myopia |
Non-Patent Citations (3)
Title |
---|
中原医刊15(5) 1988.5.31 苏应和 中药治疗近视236例观察 * |
辽宁中医杂志21(8) 1994.8.31 张正贤等 抗近视治疗方治疗近视眼321例 * |
辽宁中医杂志21(8) 1994.8.31 张正贤等 抗近视治疗方治疗近视眼321例;中原医刊15(5) 1988.5.31 苏应和 中药治疗近视236例观察 * |
Also Published As
Publication number | Publication date |
---|---|
CN1166353A (en) | 1997-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101647908B (en) | Chinese traditional medicine for treating eyesight and preparation method and use method thereof | |
CN104306430B (en) | Cold treatment dressing of a kind of medical bio eye and preparation method thereof | |
CN106491987A (en) | A kind of treat traditional Chinese medicine fumigating steaming liquid of cataract and preparation method thereof | |
CN104524038A (en) | Traditional Chinese medicine composition for preventing and treating shortsightedness and application method thereof | |
CN111407613A (en) | Method for treating vision recovery | |
CN1062164C (en) | Oral medicine pill for curing myopia and amblyopia | |
CN108815390A (en) | A kind of Chinese medicine composition and preparation method thereof improving eyesight | |
CN1109786A (en) | Method of manufacturing eyesight-improving bag for navel treatment | |
CN104306546B (en) | A kind of Chinese medicine composition and its decoction, pill and powder for being used to treat optic atrophy | |
CN105998755A (en) | Mild-moxibustion medicine and mild-moxibustion apparatus for treating myopia and amblyopia | |
CN111759894A (en) | A Chinese medicinal composition for treating myopia, and its preparation method | |
CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
CN110507701A (en) | Promote the gel ointment and its massage application method of vision restoration | |
CN103830513A (en) | Traditional Chinese medicine preparation for treating primary glaucoma | |
CN1062165C (en) | Medicinal cream for curing myopia and weak visual acuity | |
CN103550455B (en) | Traditional Chinese medicine for treating glaucoma | |
CN117883524B (en) | Liver nourishing and eyesight improving composition and preparation method and application thereof | |
CN107714768A (en) | A kind of Chinese medicine composition for treating interior external opculopathy disease and its preparation method and application | |
CN110934736A (en) | Four-white gymnastics and acupoint pressure stimulation acupoint application comprehensive physiotherapy method | |
CN111012851A (en) | Traditional Chinese medicine external application hot compress eye bag for treating myopia | |
CN1192927A (en) | Fumigant of Chinese medicine for treatment of myopia and preparation method therefor | |
CN1122233A (en) | Oral medicine and fumigant liquid for myopia | |
CN1136906C (en) | Medicine for preventing and treating myopia and amlyopia | |
CN104524036A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method thereof | |
CN115414318A (en) | A topical Chinese medicinal composition for preventing and treating myopia, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |